Proton-pump inhibitor therapy for gastroesophageal reflux disease: Does it treat the asthma?

Chest

Volumn 127, Issue 4, 2005, Pages 1097-1098

  Jain, Subin ^a,b,c  

^a University of Louisville Health Sciences Center ^*

^b University of Louisville School of Medicine   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIASTHMATIC AGENT; OMEPRAZOLE; PROTON PUMP INHIBITOR; PROTON PUMP;

ASTHMA; DISEASE ASSOCIATION; DISEASE CONTROL; EDITORIAL; ENDOSCOPY; ESOPHAGITIS; ESOPHAGUS PH; GASTROESOPHAGEAL REFLUX; HUMAN; PATIENT MONITORING; PREVALENCE; PRIORITY JOURNAL; STOMACH FUNDOPLICATION; TREATMENT FAILURE; TREATMENT OUTCOME; DRUG ANTAGONISM; NOTE; PH;

ASTHMA; GASTROESOPHAGEAL REFLUX; HUMANS; HYDROGEN-ION CONCENTRATION; PROTON PUMPS;

EID: 19044386866     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.127.4.1097     Document Type: Editorial

References (14)

1. Delaney BC. Review article: prevalence and epidemiology of gastroesophageal reflux disease. Aliment Pharmacol Ther 2004; 20(suppl):2-4
2. Tobin RW, Pope CE II, Pellegrine CA, et al. Increased prevalence of gastroesophageal reflux in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998; 158:1804-1808
3. Casanova C, Baudet JS, del Valle Velasco M, et al. Increased gastroesophageal reflux disease in patients with severe COPD. Eur Respir J 2004; 23:841-845
4. Irwin RS, Curley FJ, French CL. Difficult to control asthma: contributing factors and outcome of a systematic management protocol. Chest 1993; 103:1662-1669
5. Kiljander TO, Salomaa EM, Hietanen EK, et al. Gastroesophageal reflux in asthmatics: a double-blind, placebo-controlled crossover study with omeprazole. Chest 1999; 116:1257-1264
6. Harding SM, Richter JE, Guzzo MR, et al. Asthma and gastroesophageal reflux: acid suppressive therapy improves asthma outcome. Am J Med 1996; 100:395-405
7. Chiba N, De Gara CJ, Wilkonson JM, et al. Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis. Gastroenterology 1997; 112:1798-1810
8. Milkes D, Gerson LB, Triadafilopoulos G. Complete elimination of reflux symptoms does not guarantee normalization of intraesophageal and intragastric pH in patients with gastroesophageal reflux disease. Am J Gastroenterol 2004; 99: 991-996
9. Sontag SJ, O'Connell S, Khandelwal S, et al. Asthmatics with gastroesophageal reflux: long term results of a randomized trial of medical and surgical antireflux therapies. Am J Gastroenterol 2003; 98:987-999
10. Tardiff C, Nouvet G, Denis P, et al. Surgical treatment of gastroesophageal reflux in ten patients with severe asthma. Respiration 1989; 56:110-115
11. Larrain A, Carrasco E, Galleguillos F, et al. Medical and surgical treatment of non-allergic asthma associated with gastroesophageal reflux. Chest 1991; 99:1330-1336
12. Tamhankar AP, Peters JH, Portale G, et al. Omeprazole does not reduce gastroesophageal reflux: new insights using multichannel intraluminal impedance technology. J Gastrointest Surg 2004; 8:888-896
13. Vela MF, Camacho-Lobato L, Srinivasan R, et al. Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole. Gastroenterology 2001; 120:1599-1606
14. Rosen R, Nurko S. The importance of multichannel intraluminal impedance in the evaluation of children with persistent respiratory symptoms. Am J Gastroenterol 2004; 99:2452-2458